R Metz

426 total citations
25 papers, 328 citations indexed

About

R Metz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, R Metz has authored 25 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in R Metz's work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (6 papers) and Nausea and vomiting management (3 papers). R Metz is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (6 papers) and Nausea and vomiting management (3 papers). R Metz collaborates with scholars based in France, United States and Belgium. R Metz's co-authors include P. Fargeot, B Chevallier, Jacques Bonneterre, J Bons, M. Spielmann, Éric Pujade-Lauraine, M. Tubiana-Hulin, P. Fumoleau, G Mathé and R Plagne and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and The Prostate.

In The Last Decade

R Metz

23 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Metz France 10 138 105 95 51 48 25 328
Sayaka Otake Japan 7 155 1.1× 70 0.7× 104 1.1× 37 0.7× 38 0.8× 19 397
James D. McHattie Canada 9 118 0.9× 137 1.3× 34 0.4× 23 0.5× 90 1.9× 17 354
Anna de Fazio Australia 11 58 0.4× 94 0.9× 49 0.5× 45 0.9× 32 0.7× 22 359
F. Desiderio Italy 7 111 0.8× 32 0.3× 33 0.3× 37 0.7× 44 0.9× 15 322
C Praga Italy 9 112 0.8× 29 0.3× 50 0.5× 28 0.5× 45 0.9× 26 299
M. Kevin Barry United States 10 112 0.8× 198 1.9× 94 1.0× 24 0.5× 104 2.2× 12 386
Carlo Basurto Italy 9 173 1.3× 155 1.5× 25 0.3× 25 0.5× 110 2.3× 20 379
S. L. Chew United Kingdom 9 101 0.7× 123 1.2× 64 0.7× 33 0.6× 18 0.4× 11 529
A Nakase Japan 9 189 1.4× 248 2.4× 28 0.3× 18 0.4× 138 2.9× 41 418
Penny Powers United States 6 152 1.1× 32 0.3× 80 0.8× 23 0.5× 49 1.0× 13 372

Countries citing papers authored by R Metz

Since Specialization
Citations

This map shows the geographic impact of R Metz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Metz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Metz more than expected).

Fields of papers citing papers by R Metz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Metz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Metz. The network helps show where R Metz may publish in the future.

Co-authorship network of co-authors of R Metz

This figure shows the co-authorship network connecting the top 25 collaborators of R Metz. A scholar is included among the top collaborators of R Metz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Metz. R Metz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metz, R, et al.. (2011). [Popliteal artery entrapment syndrome: suggestions for diagnostic and therapeutic clues].. PubMed. 155(18). A2580–A2580. 1 indexed citations
2.
3.
4.
Bonneterre, Jacques, P. Fargeot, R Metz, et al.. (1991). Tetracosactrin vs. methylprednisolone in the prevention of emesis in patients receiving FEC regimen for breast cancer. European Journal of Cancer and Clinical Oncology. 27(7). 849–852. 2 indexed citations
5.
Bonneterre, Jacques, B Chevallier, R Metz, et al.. (1990). A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.. Journal of Clinical Oncology. 8(6). 1063–1069. 90 indexed citations
6.
Chevallier, B, Alain Monnier, R Metz, et al.. (1990). Phase II Study of Oral Idarubicin in Elderly Patients with Advanced Breast Cancer. American Journal of Clinical Oncology. 13(5). 436–439. 19 indexed citations
7.
Cappelaere, P, J. Vignoud, P. Fargeot, et al.. (1990). [Palliative chemotherapy of epidermoid carcinoma of the upper respiratory and digestive tracts with a combination of carboplatin and 5-fluorouracil].. PubMed. 77(11). 1099–105. 2 indexed citations
8.
Fumoleau, P., David S. Horner, J Chauvergne, et al.. (1990). [Phase II trial as 2nd line chemotherapy with 5 fluorouracil and cisplatin (5FU-CDDP) for advanced breast cancer].. PubMed. 77(8). 805–10. 7 indexed citations
9.
Metz, R, M. Namer, B. Audhuy, et al.. (1988). Zoladex as Primary Therapy in Advanced Pro static Cancer A French Cooperative Trial. American Journal of Clinical Oncology. 11. S112–114. 11 indexed citations
10.
Jl, Misset, R Metz, R Keiling, et al.. (1987). Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rate.. PubMed. 7(4B). 737–40. 2 indexed citations
11.
Jasmin, C, N. Delépine, G. Delépine, et al.. (1987). [Adjuvant treatment of osteosarcomas. Experience of the Group for the Study of Bone Tumors].. PubMed. 73 Suppl 2. 90–2. 1 indexed citations
12.
Mathé, G, L Schwarzenberg, D. Machover, et al.. (1986). Phase II trial with D‐Trp‐6‐LH‐RH in prostatic carcinoma: Comparison with other hormonal agents. The Prostate. 9(4). 327–342. 16 indexed citations
13.
Mathé, G, Misset Jl, R Plagne, et al.. (1986). Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.. PubMed. 12(1-3). 143–5. 1 indexed citations
14.
Metz, R, Miguel Delgado‐Rodríguez, R Keiling, et al.. (1985). Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancer. Investigational New Drugs. 3(2). 163–166. 3 indexed citations
15.
Mathé, G, J.L. Misset, R Keiling, et al.. (1984). An oriented phase-II trial ofd-Trp6-LH-RH in patients with prostatic carcinoma. Medical Oncology and Tumor Pharmacotherapy. 1(2). 119–122. 9 indexed citations
16.
Serrou, B, H Sancho-Garnier, P Cappelaere, et al.. (1982). Follow-Up Results from a Randomized Trial for T3 and T4 Breast Cancer Patients: Previous BCG Immunotherapy Improves Response to Chemotherapy in the Relapse Patient. Recent results in cancer research. 80. 157–161. 1 indexed citations
17.
Bey, P., et al.. (1981). [Combined hyperthermia, radiotherapy and chemotherapy: preliminary clinical results (author's transl)].. PubMed. 68(3). 286–92. 1 indexed citations
18.
Serrou, B, et al.. (1981). Cipropride in Preventing Nausea and Vomiting Induced by Severely Emetic Cytostatic Agents. Journal of International Medical Research. 9(5). 390–391. 2 indexed citations
19.
Serrou, B, H Sancho-Garnier, P Cappelaere, et al.. (1979). Results of a Randomized Trial of Prophylactic Chemotherapy in T3-T4 Breast Cancer Patients Previously Treated by Radiotherapy. Recent results in cancer research. 68. 105–108. 8 indexed citations
20.
Metz, R & William Cooper. (1958). Salt Retention and Uraemia in Brain Injury. BMJ. 1(5068). 435–438. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sayaka Otake Breakdown of academic impact, for papers by James D. McHattie Breakdown of academic impact, for papers by Anna de Fazio Breakdown of academic impact, for papers by F. Desiderio Breakdown of academic impact, for papers by C Praga Breakdown of academic impact, for papers by M. Kevin Barry Breakdown of academic impact, for papers by Carlo Basurto Breakdown of academic impact, for papers by S. L. Chew Breakdown of academic impact, for papers by A Nakase Breakdown of academic impact, for papers by Penny Powers
Rankless by CCL
2026